Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06099639
Title Medical Access Program for Patritumab Deruxtecan
Recruitment Available
Gender both
Phase Expanded access
Variant Requirements No
Sponsors Daiichi Sankyo, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Highlands Oncology AVAILABLE Springdale Arkansas 72762 United States Details
University of Colorado AVAILABLE Aurora Colorado 80045 United States Details
Yale-New Haven Hospital AVAILABLE New Haven Connecticut 06510 United States Details
Advent Health AVAILABLE Orlando Florida 32804 United States Details
University of Chicago Medical Center AVAILABLE Chicago Illinois 60637 United States Details
Block Medical Center AVAILABLE Skokie Illinois 60077 United States Details
Baptist Health Lexington AVAILABLE Lexington Kentucky 40503 United States Details
Mayo Clinic AVAILABLE Rochester Minnesota 55905 United States Details
Overlook Medical Center AVAILABLE Summit New Jersey 07901 United States Details
Roswell Park Comprehensive Cancer Center AVAILABLE Buffalo New York 14263 United States Details
The Mount Sinai Hospital- (Icahn School of Medicine) AVAILABLE New York New York 10029 United States Details
Messino Cancer Center AVAILABLE Asheville North Carolina 28806 United States Details
Duke Cancer Institute AVAILABLE Durham North Carolina 27710 United States Details
Providence Portland Medical Center AVAILABLE Portland Oregon 97213 United States Details
The Kaiser Permanente Medical Group AVAILABLE Portland Oregon 97227 United States Details
Texas Oncology AVAILABLE Pearland Texas 77584 United States Details
Peace Health AVAILABLE Bellingham Washington 98225 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field